C18ORF54 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.641200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.834800E-01
Normal-vs-Stage2
7.152600E-01
Normal-vs-Stage3
2.283600E-01
Normal-vs-Stage4
8.862000E-01
Stage1-vs-Stage2
5.261400E-01
Stage1-vs-Stage3
6.022600E-01
Stage1-vs-Stage4
4.652000E-01
Stage2-vs-Stage3
3.343200E-01
Stage2-vs-Stage4
8.198800E-01
Stage3-vs-Stage4
2.896600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.906800E-01
Normal-vs-AfricanAmerican
4.386400E-01
Normal-vs-Asian
1.135840E-01
Caucasian-vs-AfricanAmerican
6.433000E-01
Caucasian-vs-Asian
3.148400E-02
AfricanAmerican-vs-Asian
4.198200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.211800E-01
Normal-vs-Female
8.804400E-01
Male-vs-Female
9.532400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.210800E-01
Normal-vs-Age(41-60Yrs)
9.936000E-01
Normal-vs-Age(61-80Yrs)
4.905800E-01
Normal-vs-Age(81-100Yrs)
4.196400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.032400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.099200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.629000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
7.004000E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.591410E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.174000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.642190E-01
Normal-vs-Daily Drinker
9.922200E-02
Normal-vs-Weekly Drinker
8.551400E-01
Normal-vs-Occasional Drinker
8.746200E-01
Normal-vs-Social Drinker
8.460000E-01
Non Drinker-vs-Daily Drinker
9.708000E-01
Non Drinker-vs-Weekly Drinker
1.963570E-01
Non Drinker-vs-Occasional Drinker
8.556300E-02
Non Drinker-vs-Social Drinker
1.446000E-01
Daily Drinker-vs-Weekly Drinker
1.992790E-01
Daily Drinker-vs-Occasional Drinker
8.361600E-02
Daily Drinker-vs-Social Drinker
1.435760E-01
Weekly Drinker-vs-Occasional Drinker
5.957400E-01
Weekly Drinker-vs-Social Drinker
5.731800E-01
Occasional Drinker-vs-Social Drinker
9.374200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
5.852600E-01
Normal-vs-Grade 2
6.289000E-01
Normal-vs-Grade 3
6.293200E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.062200E-03
Grade 1-vs-Grade 3
5.564200E-03
Grade 1-vs-Grade 4
5.852600E-01
Grade 2-vs-Grade 3
9.778200E-01
Grade 2-vs-Grade 4
6.289000E-01
Grade 3-vs-Grade 4
6.293200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.520000E-01
Normal-vs-NonDiabetic
6.820600E-01
Diabetic-vs-NonDiabetic
5.408400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.807200E-01
Normal-vs-NoPancreatitis
6.417200E-01
Pancreatitis-vs-NoPancreatitis
6.091200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.780200E-01
Normal-vs-N1
7.622200E-01
N0-vs-N1
2.994600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
8.538800E-01
Normal-vs-TP53-NonMutant
4.000400E-01
TP53-Mutant-vs-TP53-NonMutant
1.789160E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
